Interferon-gamma or granulocyte-macrophage colony-stimulating factor administered as adjuvants with a vaccine of irradiated autologous tumor cells from short-term cell line cultures: a randomized phase 2 trial of the cancer biotherapy research group.

Dillman, R O; Wiemann, M; Nayak, S K; DeLeon, C; Hood, K; DePriest, C

Dillman, R O; Wiemann, M; Nayak, S K; DeLeon, C; Hood, K; DePriest, C.

Affiliation

Dillman RO; Hoag Cancer Center, Newport Beach, California 92658, USA. rdillman@hoaghospital.org

J Immunother ; 26(4): 367-73, 2003.

Article de En | MEDLINE | ID: mdl-12843799

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adjuvants immunologiques / Facteur de stimulation des colonies de granulocytes et de macrophages / Interféron gamma / Vaccins anticancéreux / Tumeurs Type d'étude: Clinical_trials Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Immunother Sujet du journal: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Année: 2003 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links